Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7826793rdf:typepubmed:Citationlld:pubmed
pubmed-article:7826793lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7826793lifeskim:mentionsumls-concept:C0023911lld:lifeskim
pubmed-article:7826793lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:7826793lifeskim:mentionsumls-concept:C0683956lld:lifeskim
pubmed-article:7826793pubmed:issue5lld:pubmed
pubmed-article:7826793pubmed:dateCreated1995-2-21lld:pubmed
pubmed-article:7826793pubmed:abstractTextHyperfibrinolytic activity occurs frequently during liver transplantation in cirrhotic patients. In order to identify those patients at high risk for increased intraoperative blood loss before operation, we determined predictive indicators of hyperfibrinolysis. We studied 56 cirrhotic patients undergoing liver transplantation with the same anaesthetic procedure and transfusion regimen. The preoperative coagulation patterns of the 11 patients who experienced acute intraoperative hyperfibrinolytic activity were compared with those of the 45 patients who did not suffer this complication. Before surgery, patients with intraoperative hyperfibrinolysis had decreased prothrombin time (PT) and euglobulin lysis time (ELT), and increased thrombin time (TT) and fibrinogen degradation products (FDP), whereas alpha angle and maximum amplitude (MA) were reduced on thrombelastography. Stepwise multivariate analysis disclosed three components which were significantly linked with occurrence of hyperfibrinolysis: TT, FDP and MA. Their sensitivity, specificity, positive and negative predictive values demonstrated that patients with FDP > or = 48 mg litre-1 and MA < or = 35 mm before incision had 100% probability of developing hyperfibrinolytic activity during transplantation.lld:pubmed
pubmed-article:7826793pubmed:languageenglld:pubmed
pubmed-article:7826793pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826793pubmed:citationSubsetIMlld:pubmed
pubmed-article:7826793pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7826793pubmed:statusMEDLINElld:pubmed
pubmed-article:7826793pubmed:monthNovlld:pubmed
pubmed-article:7826793pubmed:issn0007-0912lld:pubmed
pubmed-article:7826793pubmed:authorpubmed-author:OtteniJ CJClld:pubmed
pubmed-article:7826793pubmed:authorpubmed-author:LevySSlld:pubmed
pubmed-article:7826793pubmed:authorpubmed-author:BoudjemaKKlld:pubmed
pubmed-article:7826793pubmed:authorpubmed-author:SteibAAlld:pubmed
pubmed-article:7826793pubmed:authorpubmed-author:GROUTR ERElld:pubmed
pubmed-article:7826793pubmed:authorpubmed-author:GengenwinNNlld:pubmed
pubmed-article:7826793pubmed:issnTypePrintlld:pubmed
pubmed-article:7826793pubmed:volume73lld:pubmed
pubmed-article:7826793pubmed:ownerNLMlld:pubmed
pubmed-article:7826793pubmed:authorsCompleteYlld:pubmed
pubmed-article:7826793pubmed:pagination645-8lld:pubmed
pubmed-article:7826793pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:meshHeadingpubmed-meshheading:7826793-...lld:pubmed
pubmed-article:7826793pubmed:year1994lld:pubmed
pubmed-article:7826793pubmed:articleTitlePredictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients.lld:pubmed
pubmed-article:7826793pubmed:affiliationService of Anaesthesiology, University Hospital Strasbourg-Hautepierre, France.lld:pubmed
pubmed-article:7826793pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7826793lld:pubmed